Mannatech (NASDAQ:MTEX) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a research note published on Saturday. The firm issued a buy rating on the stock.

Mannatech Stock Performance

MTEX opened at $7.82 on Friday. The company’s 50 day moving average is $7.68 and its 200 day moving average is $7.55. The company has a current ratio of 1.17, a quick ratio of 0.62 and a debt-to-equity ratio of 0.54. The company has a market cap of $14.70 million, a price-to-earnings ratio of -12.41 and a beta of 1.17. Mannatech has a 12-month low of $6.75 and a 12-month high of $10.51.

Mannatech (NASDAQ:MTEX) last posted its quarterly earnings data on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%. The company had revenue of $27.74 million for the quarter.

Insider Buying and Selling

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the firm’s stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $7.75, for a total transaction of $126,232.00. Following the sale, the director now directly owns 54,721 shares of the company’s stock, valued at $424,087.75. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 41.50% of the stock is currently owned by insiders.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.